Reactome | Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Schema > LiteratureReference > Entries

Improved survival with vemurafenib in melanoma with BRAF V600E mutation Show undefined attributes

author	[Person:6798826] Chapman, PB [Person:6798880] Hauschild, A [Person:6798976] Robert, C [Person:6798878] Haanen, JB [Person:6798816] Ascierto, P [Person:6798913] Larkin, J [Person:6798851] Dummer, R [Person:6798867] Garbe, C [Person:6799013] Testori, A [Person:6798939] Maio, M [Person:5609791] Hogg, D [Person:6798936] Lorigan, P [Person:6798921] Lebbe, C [Person:6798898] Jouary, T [Person:4086361] Schadendorf, D [Person:6798974] Ribas, A [Person:6798963] O'Day, SJ [Person:6799003] Sosman, JA [Person:6798907] Kirkwood, JM [Person:6798852] Eggermont, AM [Person:442388] Dreno, B [Person:6798959] Nolop, K [Person:6798931] Li, J [Person:6798953] Nelson, B [Person:6798887] Hou, J [Person:6798926] Lee, RJ [Person:6798860] Flaherty, KT [Person:6798943] McArthur, GA
created	[InstanceEdit:6799051] Rothfels, Karen, 2015-09-21
dbId	6799050
displayName	Improved survival with vemurafenib in melanoma with BRAF V600E mutation
journal	N. Engl. J. Med.
pages	2507-16
pubMedIdentifier	21639808
schemaClass	LiteratureReference
title	Improved survival with vemurafenib in melanoma with BRAF V600E mutation
url	http://www.ncbi.nlm.nih.gov/pubmed/21639808
volume	364
year	2011

Referrals

(literatureReference)

[Reaction:R-HSA-6802930] Dimerization of BRAF V600E splice variants contributes to BRAF inhibitor resistance

(author)

© 2026 Reactome

Cite Us!